NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









MicroTransponder

MicroTransponder

Private
Austin, TexasHealthcare & Life Scienceshttps://www.vivistim.com/

Last Round

Series F

Mar 12, 2025

Est. Valuation

$225M

Total Funding Raised

$176.84M

Company Overview

MicroTransponder is a medical technology company that develops nerve stimulation-based therapies aimed at treating stroke rehabilitation, tinnitus, and various neurological conditions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

Paired Vagus Nerve Stimulationstroke rehabilitationneurostimulationvagus nerve stimulationVNSimplantable medical devicestroke recoveryneurotechbioelectronic medicinemotor function restorationFDA approved deviceneuroplasticityMedicare reimbursementBreakthrough Device designationstroke centers

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MicroTransponder Comps

Public and private peers based on sector, stage, and business model.

MicroTransponder comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

MicroTransponder Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series FMar 12, 2025
Series ESep 21, 2022
DebtSep 8, 2020
Series CNov 17, 2017
VC RoundDec 10, 2015
VC Round
Aug 29, 2013

MicroTransponder Investors

Notable investors and investment history

MicroTransponder investors
InvestorRounds
Longitude CapitalSeries F
The Vertical GroupSeries E, Series F
Action Potential Venture CapitalSeries E, Series F
U.S. Venture PartnersSeries E, Series F
Osage University PartnersSeries E, Series F
GPG VenturesSeries E, Series F
National Institute of Neurological Disorders and Stroke (NINDS)Grant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 25, 2025

    Medicare payment change announced for Vivistim procedure, improving reimbursement and market access.

  • Nov 17, 2025

    Cynthia Lucchese joins as an independent director.

MicroTransponder Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MicroTransponder Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MicroTransponder's valuation, stock price, and market status.

Firmographic Details

HeadquartersAustin, Texas
Year Founded2007
Last FundingMar 12, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.